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Brominated ﬂame retardants (BFRs) are incorporated intoa wide
variety of consumer products, are readily released into home and
work environments, and are present in house dust. Studies using
animal models have revealed that exposure to polybrominated
diphenyl ethers (PBDEs) may impair adult male reproductive
function and thyroid hormone physiology. Such studies have
generally characterized the outcome of acute or chronic exposure
to a single BFR technical mixture or congener but not the impact of
environmentally relevant BFR mixtures. We tested whether
exposure to the BFRs found in house dust would have an adverse
impact on the adult male rat reproductive system and thyroid
function. Adult male Sprague Dawley rats were exposed to
a complex BFR mixture composed of three commercial brominated
diphenyl ethers (52.1% DE-71, 0.4% DE-79, and 44.2% decaBDE-
209) and hexabromocyclododecane (3.3%), formulated to mimic the
relative congener levels in house dust. BFRs were delivered in the
diet at target doses of 0, 0.02, 0.2, 2, or 20 mg/kg/day for 70 days.
Compared with controls, males exposed to the highest dose of BFRs
displayed a signiﬁcant increase in the weights of the kidneys and
liver, which was accompanied by induction of CYP1A and CYP2B
P450 hepatic drug–metabolizing enzymes. BFR exposure did not
affect reproductive organ weights, serum testosterone levels,
testicular function, or sperm DNA integrity. The highest dose
caused thyroid toxicity as indicated by decreased serum thyroxine
(T4) and hypertrophy of the thyroid gland epithelium. At lower
doses, the thickness of the thyroid gland epithelium was reduced,
but no changes in hormone levels (T4 and thyroid-stimulating
hormone) were observed. Thus, exposure to BFRs affected liver and
thyroid physiology but not male reproductive parameters.
Key Words: brominated ﬂame retardants; mixture; house dust
exposure; adult male rats; reproductive parameters; thyroid
function; drug-metabolizing enzymes.
Brominated ﬂame retardants (BFRs) are frequently added to
electronics, home furnishings, and a variety of other consumer
items to reduce ﬂammability. Polybrominated diphenyl ethers
(PBDEs) and hexabromocyclododecane (HBCD) are among
the most widely used additive ﬂame retardants (Alaee et al.,
2003). There are three general commercial formulations of the
PBDEs, penta, octa, and decabromodiphenyl ethers (Alaee
et al., 2003). As a result of evidence of persistence and
bioaccumulation, the pentabromo and octabromo forms were
banned in Europe in 2004, in California in 2008, and U.S.
producers agreed to cease their production by 2004 (Tullo,
2003). In 2008, the Canadian government prohibited their
import, production, or sale and in 2010, recommended that
similar measures be applied to decabromodiphenyl ether
(decaBDE) (Environment Canada, 2010b). The need to meet
stringent ﬂammability standards in many jurisdictions has
resulted in producers replacing PBDEs with alternates such as
HBCD. However, a recent assessment of HBCD by the
Canadian government has proposed that HBCD be banned
based on its persistence in the environment and ability to
biomagnify through food chains (Environment Canada,
2010a).
As neither PBDEs nor HBCD are covalently linked with the
polymers of the matrices to which they are added, they are
released readily, leading to contamination of both home and
work environments. It has been suggested that the largest
source of human exposure to PBDEs is from ingestion of
contaminated house dust (Jones-Otazo et al., 2005), which is
estimated to account for as much as 80–93% of daily exposure
in toddlers (Wilford et al., 2005). Studies of house dust in
North America have revealed that the PBDEs and HBCD were
the most prominent BFRs detected in the majority of houses
sampled (Allen et al., 2008; Stapleton et al., 2008).
The potential cumulative effects of exposure to PBDEs and
HBCD on human health are unknown although the study of the
effects of PBDEs, as either technical mixtures or individual
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lines of evidence suggest that exposure to PBDEs may impair
adult male reproductive function and thyroid hormone
physiology. Exposure to house dust concentrations of penta-
bromodiphenyl ether (pentaBDE) congeners was negatively
correlated with luteinizing and follicle-stimulating hormone
concentrations (Meeker et al., 2009) and sperm numbers and
testis size (Akutsu et al., 2008). Although decaBDE has been
detected in semen samples of Chinese workers who process
electronic waste (Liu et al., 2012), studies have not yet linked
its exposure to effects on the male reproductive system in
humans. In adult male rats, exposure to pentaBDE (van der
Ven et al., 2008a) or decaBDE (Van der Ven et al., 2008b)
reduced the weights of the epididymides and altered seminal
vesicle weights.
There is evidence that PBDEs may interfere with thyroid
hormone signaling in addition to affecting male reproductive
parameters. PentaBDE levels in adult men exposed to house
dust (Meeker et al., 2009) and in Great Lakes sport ﬁsh
consumers (Turyk et al., 2008) were positively correlated with
free thyroxine (T4); their associations with triiodothyronine
(T3) or thyroid-stimulating hormone (TSH) were variable.
In adult male rats, pentaBDE exposure decreased serum T4
levels without affecting T3 (van der Ven et al., 2008a).
Less information is available on the thyroid or male
reproductive effects of HBCD exposure. The sole study to
examine the correlation between HBCD exposure and
measures of thyroid function in humans studied mother-infant
pairs in Norway (Eggesbo et al., 2011) and failed to observe
any signiﬁcant relationship between breast milk HBCD levels
and neonatal TSH. In animal studies, HBCD did not
signiﬁcantly affect reproductive or thyroid parameters (van
der Ven et al., 2006).
Because humans are constantly exposed to complex
mixtures of BFRs, and epidemiological studies have suggested
that exposures to BFRs at environmentally relevant levels
correlate with disruption in male reproductive and thyroid
functions, our goal was to determine the effects of exposure to
the BFRs found in house dust in an animal model. We
reconstituted a complex BFR mixture based on the relative
levels reported in a representative sample of house dust in
North America (Allen et al., 2008; Stapleton et al., 2008) and
evaluated the effects of chronic exposure across a broad range
of exposure levels on adult male rats. Speciﬁc emphasis was
placed on measures of reproductive- and thyroid-related
effects.
MATERIALS AND METHODS
Mixture Formulation
The BFR mixture was composed by combining three technical commercial
mixtures of PBDEs (DE-71, DE-79, and BDE-209) and one mixture of HBCD
to yield a ratio of PBDE congeners and HBCD comparable to that observed in
house dust in Boston, MA (Allen et al., 2008; Stapleton et al., 2008)( Table 1).
The HBCD was composed of all three isomers (alpha, beta, and gamma) but
was enriched for the more environmentally stable alpha congener to represent
the composition that might be found in house dust (Roosens et al., 2009).
Technical DE-79 was purchased from Wellington Laboratories (Guelph,
Canada), and BDE-209 (> 97% pure) was purchased from Sigma-Aldrich (St
Louis, MO). DE-71 was generously provided by Doug Arnold (Health
Canada), from stock provided by Chemtura (Lawrenceville, GA). The HBCD
mixture was kindly provided by Ivan Curran (Health Canada). The BFR
formulation was dissolved in corn oil and mixed into a powdered isoﬂavone-
free rodent diet (Teklad Global 2019 diet; Harlan Laboratories, Madison, WI)
with 15% vol/wt deionized water, pelleted, and allowed to dry at room
temperature. Corn oil added to the diets amounted to 2.4 g/kg in addition to the
90 g/kg of soya oil present in this diet. Dried pellets were stored away from
light at 4C for no longer than 1 month prior to feeding. Diets contained 0,
0.25, 2.5, 25, and 250 mg of the BFR mixture/kg diet; assuming a daily food
consumption of 80 g/kg body weight/day, this formulation delivered nominal
doses of 0, 0.02, 0.2, 2.0, and 20 mg/kg body weight/day weight. The
calculation of the lowest dose was based on assumptions of dust ingestions
rates (100 mg/day) of children (16.5 kg body weight) and the scaling of dose
from humans to rodents based on body surface area (1:6.3 human to rat) rather
than weight. This dose estimates the highest levels of human exposure as
indicated by the maximum BFR levels measured in house dust in the Boston
studies (Allen et al., 2008; Stapleton et al., 2008).
Animals and Treatment
Adult Sprague Dawley male rats (350–375 g) were obtained from Charles
River (St-Constant, Canada) and maintained on a 12-L:12-D cycle in the
Animal Resources Centre of McGill University. Food and water were provided
ad libitum. All animal studies were conducted in accordance with the
procedures and principles outlined in the Guide to the Care and Use of
Experimental Animals prepared by the Canadian Council on Animal Care
(McGill Animal Research Centre protocol 5862).
Animals were housed individually, and BFR mixture  72 consumption was
monitored by measuring food weight on a weekly basis. Animals were
acclimatized on the control diet for 1 week and randomly divided into the
control and one of the BFR mixture four treatment groups (n ¼ 15 per group)
for a period of 70 days, a sufﬁcient time for germ cells to progress from
spermatogonia to mature spermatozoa. Animals were weighed and examined
physically once a week.
Tissue Collection
At the end of the 70-day treatment period, 50 rats (n ¼ 10 per group) were
euthanized by CO2 asphyxiation followed by exsanguination via cardiac
puncture. The following organs were dissected: liver, kidneys, spleen, heart,
lung, thymus, epididymis, testes, ventral prostate, vas deferens, and empty
seminal vesicles (with coagulating glands). All organs were examined,
weighed, snap frozen in liquid nitrogen, and stored at  80C. Mature
spermatozoa from the right cauda epididymidis were collected, as previously
described (Delbes et al., 2007), and stored at  80C until further analysis.
Sperm from the contralateral cauda epididymidis were collected for direct
motility analysis by computer-assisted sperm motility (CASA). The trachea,
including the thyroid gland, was gently removed and ﬁxed in neutral buffered
formalin before being processed for morphological analysis. Whole blood was
transferred to a Vacutainer SST (BD Biosciences Canada, Mississauga, ON),
allowed to clot for 30 min at room temperature, then held on ice until
centrifugation at 1300 3 g for 20 min. Serum was aliquoted and stored at
 80C until assayed.
The remaining 25 rats (n ¼ 5 per group) were anaesthetized by injection of
a cocktail containing ketamine (50 mg/kg), xylazine (5 mg/kg), and
acepromazine (1 mg/kg); the left testis was cleared with saline and perfused
with Bouin’s ﬂuid through the abdominal aorta. The tissue was then excised,
postﬁxed for an additional 24 h in the same ﬁxative, dehydrated, and embedded
in parafﬁn (Bieber et al., 2006).
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Calcium, magnesium, phosphorus, blood urea nitrogen, uric acid, albumin,
total protein, creatine kinase, creatinine, triglycerides, cholesterol, glucose,
alkaline phosphatase (ALP), and alanine aminotransferase (ALT) were
measured in the serum (n ¼ 8–10 per group) with an ABX Pentra 400 clinical
chemistry analyzer (Horiba ABX, Montpellier, France).
Liver RNA Extraction and Real-Time Quantitative Reverse Transcription-
PCR
RNAs were extracted from liver samples (n ¼ 9–10 per group) using TRIzol
(Invitrogen, Burlington, Canada) following the manufacturer’s protocol.
Brieﬂy, frozen liver samples (50–100 mg) were homogenized in 1 ml of
TRIzol using a steel ball in a Retch MM 400 mixer mill for 2 min at 25 Hz.
After TRIzol extraction, the RNA was cleaned using an RNeasy Mini kit
(Qiagen Inc., Mississauga, ON). RNA quantity and quality were assessed using
a NanoDrop spectrophotometer (ThermoFisher Scientiﬁc, Ottawa, Canada).
RNA was reverse transcribed in 20 ll reaction mix containing 1 lg total
RNA using the QuantiTech reverse transcription kit (Qiagen Inc.). Primer
sequences for Cyp1a1 (cytochrome P450, family1, member 1A1) and putative
genes responsive to thyroid hormone receptor (Me1, malic enzyme 1,
NADP(þ)-dependent, cytosolic; Dio1, deiodinase I; and Thrsp, thyroid
hormone responsive) and estrogen receptor (Apoa4, apolipoprotein A-IV;
Igbp1, insulin-like growth factor binding protein 1; Lpin1, lipin 1, and
serpinb9, serpin peptidase inhibitor, clade B [ovalbumin], member 9) are shown
in Supplementary table 1. Real-time PCR reactions using SYBR Green in
a ﬁnal volume of 25 ll were performed using a CFX96 (Bio-Rad Laboratories
Ltd, Mississauga, ON). PCR efﬁciency was examined using standard curves for
each gene. Complementary DNAs from all treatment groups were pooled,
except for Cyp1a1 where pools from the highest dose animals were used.
Relative gene expression was calculated using the CFX Manager Software,
with RNA loading correction based on the expression of two housekeeping
genes, beta actin (Actb) and hypoxanthine-guanine phosphoribosyltransferase
(Hprt).
Testis RNA Extraction and Real-time Quantitative Reverse Transcription-
PCR
Frozen left testes (n ¼ 9–10 per group) were disrupted using a mortar and
pestle followed by homogenization via a 20 gauge needle and syringe
combined with QIAshredder (Qiagen Inc.). RNA extraction was carried out
using an RNeasy Plus Mini Kit with on-column DNase digestion (Qiagen Inc.)
according to the manufacturer’s protocol. RNA concentrations were determined
using the NanoDrop 2000 (ThermoFisher Scientiﬁc), and integrity was assessed
by conventional gel electrophoresis.
Primer sequences for genes involved in steroidogenesis (Star, steroidogenic
acute regulatory protein; Cyp17a1, cytochrome P450 17-hydroxylase/lyase; Ar,
androgen receptor; Srd5a1, steroid 5-reductase 1; Srd5a2, steroid 5-reductase 2;
Cyp19a1, cytochrome P450, family 19, subfamily a, polypeptide 1; Esr1,
estrogen receptor 1, and Esr2, estrogen receptor 2) are shown in Supplementary
table 2. Real-time PCR reactions were run in duplicate using QuantiTect One-
Step SYBR Green quantitative reverse transcription PCR (qRT-PCR) kits
(Qiagen Inc.) in a volume of 20 ll with the Roche LightCycler system (Roche
Diagnostics, Laval, QC). PCR efﬁciency was examined with standard curves
for each gene utilizing RNA from control males. Relative gene expression was
normalized to 18S ribosomal RNA.
Drug-Metabolizing Enzyme Activities
A 0.5 g piece of liver (n ¼ 9–10 per group) was homogenized in
2.5 volumes (vol/wt) of cold 0.05M Tris-1.15% KCl buffer (pH 7.4). The
10,000 3 g supernatant (S9 fraction) was retained and assayed for the activities
of CYP1A1/1A2, 2B, 1A2/3A, and 2B/3A, using ethoxyresoruﬁn-(EROD),
TABLE 1
Diet Formulation
House dust levels
a Congeners in component technical mixtures (%)
Congener Median (ng/g) Percentage (%) DE-71
b (52.08%)
e DE-79
c (0.36%)
e BDE-209
d (44.18%)
e HBCD (3.38%)
e
Congener levels in
ﬁnal mixture (%)
BDE-17 1.4 0.01 0.04 0.02
BDE-28 16.3 0.16 0.37 0.19
BDE-47 1865 17.93 33.93 17.19
BDE-49 29.6 0.28 0.77 0.40
BDE-66 17.2 0.17 1.02 0.53
BDE-85 124 1.19 3.18 1.66
BDE-99 2460 23.64 41.40 0.03 21.56
BDE-100 436.3 4.19 7.10 3.70
BDE-138 20.9 0.2 0.24 0.50 0.13
BDE-153 234.4 2.25 3.75 6.17 4.18
BDE-154 182.8 1.76 3.00 0.93 1.57
BDE-183 27.9 0.27 0.08 37.20 0.18
BDE-197 2.7 0.03 21.60 0.08
BDE-207 45.9 0.44 13.70 0.05
BDE-209 4502 43.27 1.81 98.00 43.30
HBCD 3.40 99.00 3.35
aValues for PBDE congeners in dust are those reported by Allen et al. (2008), whereas total HBCD values are derived from the analyses of the same samples but
reported by Stapleton et al. (2008)
bCongener levels in technical DE-71 are those reported by Konstantinov et al. (2008).
cCongener levels in technical DE-79 are those reported in the certiﬁcate of analysis provided by supplier.
dCongener levels in BDE-209 are those reported in the certiﬁcate of analysis provided by supplier.
eAmount in ﬁnal mixture.
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ﬁn-O-dealkylase (BROD) activities, respectively, according to the method of
Burke et al. (1985), with modiﬁcations. Reactions were carried out at 37C
with triplicate samples in 96-well plates. The ﬂuorescence of resoruﬁn was
measured with a SpectraMax M2 (Molecular Devices, Sunnyvale, CA), with
excitation and emission wavelengths of 530 and 585 nm. Fluorescence values
were converted to nanomoles using standard resoruﬁn ﬂuorescence. Protein
content of the S9 fraction was measured using the Quick Start Bradford Protein
Assay (Bio-Rad Laboratories, Hercules, CA) and a standard curve of bovine
serum albumin.
Hormone Measurements
Serum testosterone concentrations were measured using a testosterone
ELISA kit (IBL Immuno-Biological Laboratories, Hamburg, Germany),
following the manufacturer’s protocol. Commercial radioimmunoassay kits
were used to assay serum thyroxine (T4; MP Biomedicals, Lachine, QC) and
TSH (MP Biomedicals). Sample size was 8–10 per group.
Histology
Testis. Testicular sections (5 lm) were cut and mounted on charged slides
and stained with hematoxylin and eosin (Sigma-Aldrich, Oakville, ON) for
overall morphological evaluation (n ¼ 5 per group). Images were captured
using a Leica DM LB2 microscope (Leica Microsystems Inc., Concord, ON)
using a 203 lens ﬁtted with an Inﬁnity-3 video camera (Lumenera Corp.,
Ottawa, ON).
Thyroid gland. Fixed thyroid glands in situ on the trachea, were embedded
in parafﬁn, sectioned (5 lm), and stained with periodic acid Schiff. The height
of the thyroid gland epithelium was measured in sections known to be either in
the interior or periphery of the gland using digital analysis of images. At least
10 images from each location (internal vs. periphery) per animal were analyzed,
and measurements of epithelial height were taken from at least ﬁve separate
follicles per image, selected using an overlaid, numbered grid, and ﬁve
randomly generated numbers. All measurements were made blindly regarding
the animal treatment (n ¼ 9–10 per group) by a single observer.
Sperm Count and Motility
Portions of the frozen left testes (n ¼ 10 per group) were thawed on ice and
homogenized in 5 ml of 0.9% saline, 0.1% merthiolate, and 0.05% Triton
X-100, for two intervals of 15 s, separated by a 30-s interval on ice. Sperm
heads (condensed spermatids and spermatozoa) were counted using a hemocy-
tometer (Robb et al., 1978).
Spermatozoal motility was measured by CASA using our previously
published method (Zubkova and Robaire, 2004). Brieﬂy, spermatozoa from
the cauda epididymidis were collected into 3 ml of motility buffer (Hanks
Balanced Salt Solution, 0.35 mg/ml sodium bicarbonate, 0.1 mg/ml sodium
pyruvate, 0.025 mg/ml soybean trypsin inhibitor, 2 mg/ml bovine serum
albumin, pH 7.4 [Gibco Invitrogen, Burlington, ON], 4.2 mg/ml 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, 0.9 mg/ml D-glucose [Sigma
Chemical Co.], prewarmed to 37C) and were allowed to disperse for 3 min.
Av o l u m eo f2 0ll of a 1:30-diluted suspension was loaded onto 2X Cel
Sperm Analysis Chambers (Hamilton-Thorne Research, Beverly, MA),
prewarmed to 37C and analyzed using a Hamilton-Thorne IVOS Motility
Analyzer, version 12 (Hamilton-Thorne Research); the following primary
parameters were obtained: average path velocity (VAP), curvilinear velocity
(VCL), straight line velocity (VSL), amplitude of lateral head displacement
(ALH), as well as two derived parameters, linearity (LIN ¼ BSL/VCL 3 100)
and straightness (STR ¼ VSL/VAP 3 100). Approximately 10,000–14,000
cauda epididymal spermatozoa were analyzed for each treatment group (n ¼
9–10 per group). Analysis was performed using the following settings: stage
temperature, 37C; frames acquired, 30; frame rate, 60 Hz; minimum contrast,
80; minimum cell size, 4 pixels; minimum static contrast, 15; cell intensity,
80; magniﬁcation, 0.82; static size limits, 0.29–8.82; and static intensity,
0.18–1.8. The chamber depth was 80 lm, where 20 ll were loaded into each
chamber.
Sperm DNA Integrity
Comet assay. DNA strand breaks in spermatozoa were evaluated using the
alkaline comet assay, as previously described (Codrington et al., 2004). Brieﬂy,
frozen sperm samples were thawed, diluted, and 50 ll of the cell suspension
(1 3 10
5 cells/ml) were mixed with molten agarose, and samples were placed
on a two-well CometSlide (Trevigen Inc., Gaithersburg, MD). Slides were
immersed in lysis buffer containing 10% dimethyl sulfoxide, 1% Triton X-100,
and 40mM dithiothreitol for 1 h on ice and then incubated for 3 h at 37Ci n
lysis buffer containing 0.1 mg/ml proteinase K. Slides were washed, kept at
4C for 10 min to reset the agarose, and immersed in freshly prepared alkaline
FIG. 1. Effects of 70-day BFR exposure on body weights and liver and
kidney weights in male rats. (A) Change in body weight during the BFR
treatment. Male rats were randomly divided into ﬁve treatment groups:
0 (control), 0.02, 0.2, 2, and 20 mg/kg/day. Animals were weighed weekly for
70–72 days and the overall change in body weight during this period is shown.
Bars represent the means ± SEM (n ¼ 15 per group). At the end of BFR
treatment, (B) liver and (C) kidneys were weighed and normalized to body
weight (BW, g/kg BW). Values are expressed as mean ± SEM (n ¼ 15 per
group). *p < 0.05 compared with control.
BROMINATED FLAME RETARDANTS IN MALE RATS 499solution (1mM EDTA and 0.05M NaOH, pH 12.1) for 45 min. Electrophoresis
was done at 14 V (0.7 V/cm) for 10 min in 13 Tris-borate-EDTA buffer, pH 8
(Mini-Sub Cell GT; Bio-Rad Laboratories). Slides were then ﬁxed in ethanol
and stored at room temperature. DNA was stained with SYBR Green
(Trevigen Inc.) (1:10,000 in Tris-EDTA buffer, pH 7.5) and immediately
analyzed using an Inﬁnity 3-1 digital camera (Lumenera Corp.) attached to
a Leica DM LB2 ﬂuorescence microscope. Fifty cells per well were selected
at random and analyzed, for a total of 100 cells per animal (n ¼ 5p e rg r o u p ) ,
and ﬂuorescent images were scored for comet parameters. Tail length, percent
tail DNA, and tail extent moment (tail length/fraction of tail DNA) were
assessed using the KOMET 5.0 image analysis system (Kinetic Imaging Ltd,
Liverpool, U.K.).
Acridine orange/sperm chromatin structure assay. To assess the
susceptibility of sperm nuclear DNA to acid-induced denaturation, the acridine
orange (AO) assay, also known as the sperm chromatin structure assay (SCSA)
(Evenson et al., 2002), was applied, as previously described (Delbes et al.,
2007; Evenson et al., 2002). Brieﬂy, sperm samples (2.5 3 10
6 cells/ml in
PBS) were thawed, sonicated on ice, and mixed with denaturation buffer (0.08
N HCl, 0.15M NaCl, and 0.1% Triton X-100, pH 1.4) for 30 s at 4Ct o
denature uncondensed sperm DNA. After 30 s, 1.2 ml of AO staining solution
(0.126M Na2HPO4, 0.037M citric acid buffer, 1mM EDTA, 0.15M NaCl, pH
6.0 containing 6 lg/ml AO [Sigma Chemical Company]) was added. Exactly 3
min following the addition of the denaturation buffer, spermatozoa were
analyzed using a FACScan ﬂow cytometer (BD Biosciences) ﬁtted with an
argon ion laser (488-nm line excitation). A positive control was obtained by
preincubating the spermatozoa with 100mM H2O2 at 56C for 45 min. The raw
data were processed using WinList software (Verity Software House, Topsham,
ME). Results were expressed as mean DNA fragmentation index (DFI),
standard deviation of DFI, percentage of DFI (% DFI, corresponding to the
percentage of cells outside the main population), and as percentage of
spermatozoa with high green ﬂuorescence or DNA stainability (% HDS), as an
indication of sperm DNA compaction (Evenson et al., 2002). A total of 10,000
AO-labeled spermatozoa per sample (n ¼ 5 per group) was analyzed and each
sample was run in duplicate.
Statistical Analyses
Data were analyzed by one-way ANOVA followed by post hoc Dunnett’s
test to compare means to control. When tests for assumptions of homogeneity
of variance and normality failed, data were log transformed and retested.
When homoscedasticity and normality were still not satisﬁed after this
transformation, data were retested using Kruskal-Wallis (K-W) ANOVA on
ranks. The level of signiﬁcance was p < 0.05. For thyroid epithelium
measures, data were analyzed by a two-way ANOVA followed by post
hoc Duncan’s multiple range test. Analyses were done using SigmaPlot
version 12 (Systat Software, Chicago, IL) or JMP statistical software version
4.0.2 (SAS Institute, Cary, NC) except for K-W ANOVA on ranks and post
hoc analyses, which were performed using SigmaStat version 3.5 (Systat
Software).
RESULTS
The 70-day exposure to the BFR mixture did not affect
survival; rats appeared normal, with no hair loss, impaired
mobility, or hunched posture. Body weight gain (Fig. 1A),
absolute body weight (Supplementary ﬁgure 1A), as well as
weekly food consumption (Supplementary figure 1B), were
unaffected. Based on an average food consumption of 30 g
per day, daily exposure for each treatment group was estimated
at 0.014, 0.14, 1.39, and 14.0 mg/kg/day (Supplementary
table 3), resulting in 68–70% of target doses. Therefore, the
lowest dose to which the rats were exposed was 0.007 mg/kg
pentaBDE, 0.006 mg/kg decaBDE, 0.0005 mg/kg HBCD, and
0.00005 mg/kg octaBDE.
The highest BFR dose signiﬁcantly increased relative liver
(Fig. 1B) and kidney (Fig. 1C) weights compared with control.
There were no effects of exposure on spleen, thymus, lung, or
heart weights (data not shown). To determine the effects of
BFR on various organ systems, a variety of parameters of
serum biochemistry were assessed (Table 2). Of these, only
glucose was signiﬁcantly reduced at the highest BFR exposure
TABLE 2
Serum Biochemistry
BFR mixture nominal doses (mg/kg/day)
Parameter Control (0) 0.02 0.2 2 20 p
Calcium (mg/dl) 13.7 ± 0.2 (10) 13.6 ± 0.2 (8) 13.2 ± 0.3 (9) 13.6 ± 0.2 (10) 13.4 ± 0.2 (10) 0.51
Magnesium (mg/dl) 3.40 ± 0.10 (8) 3.65 ± 0.10 (7) 3.49 ± 0.09 (7) 3.52 ± 0.11 (9) 3.42 ± 0.10 (8) 0.51
Phosphorus (mg/dl) 9.11 ± 0.34 (8) 9.71 ± 0.30 (6) 9.65 ± 0.54 (7) 10.2 ± 0.42 (9) 9.38 ± 0.26 (10) 0.30
Blood urea N 17.1 ± 0.82 (9) 17.2 ± 0.53 (9) 17.1 ± 0.78 (9) 17.5 ± 0.55 (10) 17.5 ± 0.49 (10) 0.99
Uric acid (mg/dl) 3.18 ± 0.34 (10) 2.62 ± 0.25 (9) 2.89 ± 0.27 (9) 2.47 ± 0.31 (10) 2.09 ± 0.25 (10) 0.096
Albumin (g/dl) 3.40 ± 0.05 (8) 3.41 ± 0.10 (4) 3.42 ± 0.04 (7) 3.38 ± 0.05 (8) 3.44 ± 0.05 (6) 0.96
Total protein (g/dl) 7.77 ± 0.10 (10) 7.97 ± 0.12 (8) 7.81 ± 0.13 (9) 7.91 ± 0.14 (10) 7.95 ± 0.11 (10) 0.71
Creatinine kinase (U/l) 227 ± 22 (9) 179 ± 14 (9) 215 ± 29 (9) 275 ± 41 (10) 383 ± 87 (10) 0.20
Creatinine (mg/dl) 0.53 ± 0.02 (9) 0.49 ± 0.02 (9) 0.50 ± 0.01 (9) 0.49 ± 0.01 (10) 0.49 ± 0.01 (10) 0.37
Triglycerides (mg/dl) 184 ± 29 (8) 226 ± 29 (8) 177 ± 19 (7) 248 ± 49 (10) 173 ± 35 (8) 0.48
Cholesterol (mg/dl) 109 ± 5 (10) 117 ± 7 (9) 118 ± 8 (9) 118 ± 7 (10) 127 ± 8 (10) 0.48
Glucose (mg/dl) 296 ± 16 (9) 283 ± 9 (9) 289 ± 16 (8) 255 ± 15 (10) 238 ± 15* (9) 0.03
ALP (U/l) 184 ± 16 (8) 199 ± 21 (6) 202 ± 17 (8) 191 ± 18 (10) 187 ± 9 (8) 0.95
ALT (U/l) 67.9 ± 3.6 (10) 64.9 ± 3.6 (9) 75.4 ± 6.3 (8) 65.4 ± 2.1 (10) 69.5 ± 3.8 (10) 0.40
Notes. Values are expressed as mean ± SEM of (n) observations per treatment. Values in bold are signiﬁcantly different from control.
*p < 0.05 compared with control.
500 ERNEST ET AL.level (p ¼ 0.03). Uric acid showed a dose-related decrease, but
this effect was not statistically signiﬁcant (p ¼ 0.096; Table 2).
To further evaluate the effects of BFR exposure, RNA levels
and the catalytic activities of drug-metabolizing enzymes in the
liver were measured. The highest BFR dose signiﬁcantly
increased Cyp1a1 messenger RNA (mRNA) levels by 50-fold
(Fig. 2) and its EROD catalytic activity by 4.6-fold (Fig. 3A),
in addition to increasing MROD (CYP2B activity, 3.2-fold)
and PROD (CYP2B/3A activity, 5.6-fold) activities, compared
with controls (Figs. 3B and C). The CYP1A2/3A-mediated
BROD activity showed a dose-dependent increase in both the 2
(2-fold) and 20 (8.9-fold) mg/kg/day BFR exposure groups
(Fig. 3D), suggesting that BROD may represent a more
sensitive marker of response to our BFR mixture.
Various male reproductive parameters were evaluated
following the 70-day BFR treatment. Androgen-responsive
organ weights (Figs. 4A–E) and serum testosterone levels
(Fig. 4F) were unaffected by BFR exposure. Although
testosterone levels appeared to increase with BFR exposure,
this did not reach statistical signiﬁcance (p ¼ 0.78); the
variability observed may be due to the pulsatile nature of
testosterone secretion (Bartke et al., 1973). BFR exposure had
no observable effect on testicular sperm count (Supplementary
figure 2). Testicular histology did not reveal signiﬁcant
morphological changes in seminiferous tubular structure or in
cellular composition between controls and animals in the
highest BFR dose group (Supplementary figure 3).
Motility of spermatozoa isolated from the cauda epididymi-
dis was also analyzed. There were no effects on sperm motility
or motion parameters (Supplementary table 4). As toxicants
may still affect sperm chromatin integrity without observable
effects on sperm counts, motility, or testicular histology
(Delbes et al., 2010), DNA integrity in caudal sperm was also
FIG. 2. Effects of BFR exposure on liver Cyp1a1 mRNA levels. Relative
levels of hepatic Cyp1a1 mRNA were determined by qRT-PCR and normalized
to both Actb and Hprt, then compared with control levels. Values are expressed
as mean ± SEM (n ¼ 9–10 per group). *p < 0.01 compared with control.
FIG. 3. Effects of BFR exposure on the hepatic activities of drug-metabolizing enzymes. The activities of ethoxy-(EROD) (A), methoxy-(MROD) (B),
propyloxy-(PROD) (C), and benzyloxy-(BROD) (D)-resoruﬁn-O-deethylation were measured in hepatic S9 fractions prepared from frozen liver tissues, as
described in the text. Activities were corrected for S9 protein levels and are expressed as mean ± SEM (n ¼ 9–10 per group). *p < 0.05 compared with control.
BROMINATED FLAME RETARDANTS IN MALE RATS 501assessed. BFR treatment did not induce sperm DNA single or
double strand breaks, as measured by the COMET assay
(Supplementary figure 4), and did not affect the susceptibility
of the spermatozoa to low pH denaturation, as assessed by the
SCSA assay (Supplementary figure 5).
To further assess the impact of BFR treatment on testicular
function, the RNA expression of key genes involved in the
steroidogenesis pathway was examined by qRT-PCR (Supple-
mentary figure 6). Although there was an overall treatment
effect on Ar gene expression, the differences were not
signiﬁcant compared with control and were not dose related.
No signiﬁcant changes in the relative mRNA expression of any
of the other genes were observed.
To assess BFR effects on thyroid physiology, serum T4 and
TSH levels were measured (Fig. 5). In the group exposed to
the highest BFR dose, T4 levels were signiﬁcantly reduced to
73% of control levels (p < 0.0001; Fig. 5A), but TSH
levels were unchanged (Fig. 5B). Although serum thyroid
hormone levels indicate immediate effects of chemical
exposure on the hypothalamic-pituitary-thyroid (HPT) axis,
thyroid gland histomorphology provides a more integrated
and persistent indicator of adverse chemical effects on
thyroid hormone physiology. Qualitative evaluation of the
inner follicles of thyroid glands did not reveal pathological
changes induced by BFR exposure with the exception of
increased vacuolation of the luminal apices of epithelial cells
apparent in high dose animals (Fig. 6). Thyroid epithelial
thickness (a reliable indicator of TSH stimulation) was
measured in two general locations in the thyroid gland
(inner and outer follicles) to determine if these sites, known to
have different levels of physiological activity (Low, 1982),
respond differently to BFRs. As expected, inner follicles had
thicker epithelia than outer follicles (9.85 ± 1.2 vs. 4.74 ±
0.99 lm for inner vs. outer, respectively, p < 0.001) across all
doses, reﬂecting the increased sensitivity of the inner follicles
to TSH. Exposure to the BFR mixture caused a biphasic
response in epithelial thickness in the inner follicles, with
a reduction in thickness in response to lower doses but
a signiﬁcant increase at the highest dose (Fig. 7A). Follicles at
the periphery showed no change in epithelial thickness in
response to any dose of the ﬂame retardant mixture (Fig. 7B).
To determine if BFR exposure inﬂuenced thyroid hormone
action at the level of a target tissue, as reported for structurally
similar compounds such as polychlorinated biphenyls
(PCBs) (Bansal and Zoeller, 2008), we investigated the
expression of several thyroid hormone–regulated genes in the
liver (Table 3). Gene expression of lipogenic enzyme Me1,
known to be induced by thyroid hormone stimulation (Dozin
et al.,1 9 8 5 ), was signiﬁcantly increased in animals fed the
highest BFR-supplemented diet, despite reduction in circu-
lating T4 levels (Fig. 5). No dose of BFR signiﬁcantly altered
mRNA levels of either Thrsp or Dio1 (Table 3), although both
FIG. 4. Reproductive organ weights and serum testosterone levels in control and BFR-treated males. At the end of treatment, (A) epididymis, (B) testes, (C)
empty seminal vesicles, (D) prostate, and (E) vas deferens were weighed. Blood was collected and (F) serum testosterone concentrations were measured by ELISA.
Values are expressed as mean ± SEM (n ¼ 8–10 per group).
502 ERNEST ET AL.are positively regulated by thyroid hormone action
(Kohrle, 2002; Narayan et al., 1984). Esr-responsive genes
were also assessed because liver Me1 expression is
induced by estrogenic substances (Schmutzler et al.,2 0 0 4 );
their mRNA levels were unaffected by the BFR treatment
(Table 3).
DISCUSSION
Adult male rats exposed for 70 days to a high dose of
a complex BFR mixture mimicking the relative congener levels
in house dust showed enlargement of the liver and kidney and
altered thyroid hormone parameters; no impact on the
reproductive system was noted. This BFR mixture was
incorporated into experimental diets to deliver nominal
exposures of 0.02, 0.2, 2, and 20 mg/kg. Based on the
measured food consumption, rats ingested an average of 0.014,
0.14, 1.39, and 14.0 mg/kg/day or approximately 70% of our
target doses.
Liver and kidney weights were increased by 18 and 12%,
respectively, at the highest BFR exposure level; these increases
are within the typical range for xenobiotic exposure (Maronpot
et al., 2010) and indicative of toxicity. However, these changes
were not accompanied by increases in ALT and ALP, the usual
serum biological markers indicative of liver damage, or in
blood urea nitrogen, creatinine, and uric acid, indicative of
kidney damage. These results are not unusual because
circulating levels of these markers may not correlate well with
the degree of organ injury, and signiﬁcant increases are often
associated with severe and irreversible injury (Ennulat et al.,
2010).
Liver enlargement was associated with increased activities
in EROD/MROD and PROD activities, suggesting induction
of CYP1A1/1A2 and CYP2B P450 drug-metabolizing
enzymes, respectively. Induction of BROD, catalyzed by
CYP1A, CYP2B, and CYP3A (Burke et al., 1994), was
observed in both the 2 and 20 mg/kg/day BFR dose groups.
Although BROD does not provide a deﬁnitive measure of any
single enzyme, it does indicate that phase I enzymes were
induced at the second highest dose. Induction of EROD and
PROD activities was also reported for male rats treated with
pentaBDE (van der Ven et al., 2008a) or decaBDE (van der
Ven et al.,2 0 0 8 b ), whereas only PROD was induced in
HBCD-treated males (Germer et al.,2 0 0 6 ). Induction of
CYP1A and CYP2B suggests activation of the aryl hydro-
carbon receptor (AhR) and the constitutive androstane
receptor (CAR) pathways, respectively (Honkakoski and
Negishi, 2000).
The signiﬁcant decrease in serum glucose that was
observed may be secondary to repression of gluconeogenesis
through activation of the CAR pathway. This has also been
observed with phenobarbital-like compounds (Rushmore and
Kong, 2002). Alternatively, it may be secondary to thyroid
hormone–induced alterations in transcription of the glucose
transporter gene (Chidakel et al.,2 0 0 5 ). Our results are
consistent with observations reported after exposure to
pentaBDE (van der Ven et al.,2 0 0 8 a ) and HBCD (van der
Ven et al., 2006).
Exposure to the BFR mixture throughout all stages of male
germ cell development in adult rats had no effect on the
reproductive system, as assessed by a wide range of
parameters; these included the weights of reproductive
organs, testicular function (testosterone levels, histology,
sperm count and motility, and gene expression), and sperm
DNA integrity (COMET assay and SCSA). Our results are
consistent with observations reported after exposure of adult
male rats to several technical BFR mixtures. No effects were
seen on sperm counts (van der Ven et al., 2006, 2008a,b), and
reproductive organ weights were affected after exposure to
relatively high doses of pentaBDE (starting from 27.5 mg/kg/day)
(van der Ven et al., 2008a). In contrast, low doses of decaBDE
FIG. 5. Effects of BFR exposure on circulating (A) thyroxine (T4) and (B)
TSH. Serum collected at termination was assayed for both hormones, as
described in the text. Values are expressed as mean ± SEM (n ¼ 9–10 per
group). *p < 0.05 compared with control.
BROMINATED FLAME RETARDANTS IN MALE RATS 503(starting from 0.2 mg/kg/day) were reported to increase
seminal vesicle weights (van der Ven et al., 2008b). There is
evidence that male rats exposed during development or
weaning are likely to be more sensitive than adults to BFRs
(Stoker et al., 2005; van der Ven et al., 2009). Indeed, maternal
breast milk PBDE levels were directly correlated with the
incidence of cryptorchidism in 3-month-old boys (Main et al.,
2007). Further studies will be necessary to establish the
potential hazards of the BFR mixture to the developing male
reproductive tract.
In contrast to the apparent insensitivity of the adult male
reproductive system to BFRs, treatment with our BFR mixture
reduced serum total T4; paradoxically, this was not accompa-
nied by a compensatory increase in TSH. A variety of other
substances known to activate the AhR or CAR pathways also
have been reported to reduce circulating T4 levels with
minimal or no compensatory increase in TSH; these include
Aroclor 1254, a mixture of PCBs, phenobarbital, 3-methyl-
cholanthrene (Barter and Klaassen, 1994), and 2,3,7,8-
tetrachlorodibenzo-p-dioxin (Schuur et al., 1997).
Histomorphological analysis of the thyroid gland epithelium
revealed a biphasic effect of the BFR mixture on the HPT axis,
suggesting a thyroid hormone–like action of the mixture, at
least at the lowest dose. Epithelial thickness is largely a result
of the trophic action of TSH (Capen and Martin, 1989) and
provides an integrated measure reﬂecting the culmination of
the recent history of TSH, whereas serum levels reﬂect a single
point. Thyroid epithelial thickness was reduced at the lowest
dose of the BFR mixture, suggesting a reduction in trophic
stimulation in the gland, and was increased at the highest dose
to signiﬁcantly exceed control thickness. Although serum TSH
levels did not change with any dose of the mixture,
mechanistically relevant changes in the target organ of this
hormone suggest that the cumulative action of TSH up until
sacriﬁce was signiﬁcantly altered by the mixture. The reduction
in epithelial height at the lowest dose suggests the possibility
that (a) component(s) of the BFR mixture was acting like
thyroid hormone in suppressing TSH release. However, the
lack of change in expression of any thyroid hormone–
responsive genes (DioI and Thsrp) in the liver or genes in
the ventricles (Myh6, myosin, heavy chain 6, cardiac muscle,
alpha; Myh7, myosin, heavy chain 7, cardiac muscle, beta; Pln,
phospholamban Atp2a2, ATPase, Caþþ transporting, cardiac
muscle, and slow twitch 2; data not shown) at any dose does
not support the argument that BFRs are being converted to
thyroid hormone receptor agonists.
The sole thyroid hormone–responsive gene to show any
response was Me1 and its transcript was elevated in the livers
of animals consuming the highest BFR dose. The lack of
effect on other hepatic thyroid hormone–responsive genes
suggests that some of the Me1 response was not mediated
through the activation of a thyroid receptor. Hepatic
transcription of Me1 is also increased by treatment with
estrogenic substances in vivo (Schmutzler et al.,2 0 0 4 ). Some
PBDE metabolites have been shown to activate Esr (Kojima
et al., 2009), but the lack of change in hepatic estrogen–
responsive genes in the current study argues against Esr
activation by BFRs in the mixture. Speciﬁc induction of
hepatic Me1 gene expression has also been reported in
rats exposed to other organochlorines, such as hexachlor-
obenzene (HCB) (Loaiza-Perez et al., 1999) .T h ep r e s e n c eo f
a thyroid hormone response element in the promoter region
was essential for the HCB-induced increase in Me1
transcription in hepatoma cells in vitro. This would suggest
FIG. 6. Light micrographs (3200, periodic acid Schiff staining) of the inner follicles of thyroid glands of control (A) and BFR-treated males (B) 0.02, (C) 0.2,
(D) 2.0, or (E) 20 mg/kg/day. ‘‘c’’ indicates follicular colloid in the acellular lumen, whereas the arrow indicates the single layer of cuboidal epithelium that
surrounds and encloses the follicle. Bar ¼ 50 lm.
504 ERNEST ET AL.that the thyroid hormone receptor is required for this effect
(Loaiza-Perez et al., 1999), although HCB does not bind to
the ligand-binding domain of the thyroid hormone receptor
(Li et al.,2 0 0 8 ). Altogether, these results suggest that the
expression of Me1 is inﬂuenced by BFRs and other organo-
chlorines through an uncharacterized interaction with the
thyroid hormone receptor and thyroid hormone–responsive
elements.
In conclusion, we found no evidence that exposure to an
environmentally relevant mixture of BFRs commonly found in
North American residences presents a risk to adult male rat
reproductive function. Further analyses are currently underway
to determine whether this exposure produced serum levels
similar to those found in humans. Nevertheless, the absence of
effects on any of diverse measures of male reproductive
function across a broad range of doses, including those that
induced xenobiotic metabolism activity in the liver, provides
some assurance that adult BFR exposure does not inﬂuence
male fertility. These data provide a robust dataset for assessing
the hazard of this exposure. At the highest dose, multiple end-
points (reduced serum T4 and increased epithelial thickness
and hepatic Me1 expression) of thyroid physiology were
adversely affected. Thus, the weight of evidence argues that
thyroid hormone physiology is inﬂuenced in adult male rats by
high dose exposure to an environmentally relevant mixture of
BFRs.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
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TABLE 3
Hepatic Gene Expression
BFR mixture nominal dose (mg/kg/day)
Control (0) 0.02 0.2 2.0 20 p
Gene
Thyroid hormone receptor responsive
Me1 1.00 ± 0.19 (9) 1.02 ± 0.16 (10) 0.94 ± 0.13 (7) 1.70 ± 0.38 (9) 2.06 ± 0.28* (8) 0.006
Dio1 1.00 ± 0.09 (9) 0.86 ± 0.07 (10) 0.82 ± 0.09 (9) 1.09 ± 0.15 (10) 1.04 ± 0.08 (10) 0.27
Thrsp 1.00 ± 0.20 (9) 0.93 ± 0.11 (10) 0.92 ± 0.14 (9) 1.25 ± 0.39 (10) 1.05 ± 0.18 (10) 0.99
Estrogen receptor responsive
Apoa4 1.00 ± 0.12 (9) 0.89 ± 0.10 (10) 0.83 ± 0.04 (9) 1.12 ± 0.16 (10) 0.84 ± 0.05 (10) 0.56
Igfbp1 1.00 ± 0.21 (9) 1.35 ± 0.29 (10) 1.01 ± 0.19 (9) 1.52 ± 0.27 (10) 0.94 ± 0.15 (10) 0.32
Lpin1 1.00 ± 0.20 (9) 0.97 ± 0.24 (10) 0.81± 0.12 (9) 0.91 ± 0.24 (10) 1.19 ± 0.26 (10) 0.81
Serpinb9 1.00 ± 0.19 (9) 0.94 ± 0.15 (10) 0.93 ± 0.15 (9) 0.86 ± 0.14 (10) 1.01 ± 0.06 (10) 0.94
Notes. Values are expressed as mean levels of RNA, normalized to control levels, ± SEM of (n) observations per treatment. Values in bold are signiﬁcantly
different from control.
*p < 0.05 compared with control.
FIG. 7. Effects of BFR exposure on height of the (A) inner and (B) outer
thyroid follicular epithelium. Values are expressed as mean ± SEM (n ¼ 9–10
per group). Bars with the same letter superscript are not signiﬁcantly different.
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